UBS O'Connor’s Array Biopharma Inc ARRY Stock Holding History

UBS O'Connor’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-480,344	Closed	-$22.3M	–	386
2019 Q2	$22.3M	Buy	+480,344	New	+$13.5M	0.43%	37
2013 Q3	–	Sell	-200,000	Closed	-$908K	–	611
2013 Q2	$908K	Buy	+200,000	New	+$1.08M	0.02%	381

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS O'Connor's ARRY Position: Q3 2019 in Review

UBS O'Connor sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 480,344 shares — an estimated $22.3M sold.

UBS O'Connor first reported a position in ARRY in Q2 2013 and held it in 2 quarters. The position peaked at $22.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

UBS O'Connor reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
UBS O'Connor sold 480,344 Array Biopharma Inc shares in Q3 2019, an estimated $22.3M.
UBS O'Connor first reported a position in Array Biopharma Inc in Q2 2013 and held it in 2 quarters.
UBS O'Connor's Array Biopharma Inc position peaked at $22.3M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on UBS O'Connor's 13F filing for Q3 2019, filed 14 Nov 2019.